The increasing incidence of prostate cancer especially among aging men is the key driver of the global transrectal ultrasound (TRUS) market. This was found by Fortune Business Insights in a report, titled “Transrectal Ultrasound Market Size, Share and Global Trend by Product (Systems, Transducers), Type (Cart/Trolley Based, Portable), Application (Diagnostic, Image-guided Treatment), End User (Diagnostic Laboratories, Hospitals) and Geography Forecast till 2025”.
Some of the Main Key Players Covered in the Report
- GE Healthcare
- BK Medical Holding Company, Inc.
- Exact Imaging
- The Prometheus Group
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Fortune Business Insights predicts the global TRUS market to exhibit a CAGR of 4.5% during the forecast period. Furthermore, in 2017, the market was valued at US$ 204.8 and is anticipated to reach US$ 291.2 Mn by the end of 2025.
North America held a considerable share in the global TRUS market in 2017. High diagnostic rates of benign prostatic hyperplasia, rising prevalence of urological disorders, and robust healthcare infrastructure contributed towards the growth of this region. The demand for transrectal ultrasound procedures in Europe is also expected to rise steadily during the forecast period mainly on account of rising geriatric population and demand for minimally invasive devices.
Lifestyle Changes Leading to Rising Prevalence of Prostate Cancer in turn Fueling Demand for TRUS Devices
“The demand for effective treatment for urological abnormalities such as prostate cancer is increasing primarily due to rapid changes in lifestyle,” stated a lead analyst at Fortune Business Insights. “This is one of the chief factors driving the TRUS market,” he added. The transrectal ultrasound of prostate helps to locate the position of cysts in the male reproductive system and identify if they are cancerous or non-cancerous.
This is the reason why male population prefers transrectal ultrasound scan than any other normal tests. The healthcare infrastructure in developed and developing countries is sophisticated and well-equipped. This, coupled with better product availability, is boosting the TRUS market.
There are several other factors spelling growth in the TRUS market. Governments across regions are actively participating to ensure the early detection and timely treatment of prostate cancer. This factor, combined with technological developments, is anticipated to bode well for the TRUS market.
The global TRUS market can be segmented into the following categories:
Global Transrectal Ultrasound Market, by Product
Global Transrectal Ultrasound Market, by Type
- Cart/ Trolley-based
Global Transrectal Ultrasound Market, by Application
- Prostate Cancer
- Benign Prostatic Hyperplasia
- Image-guided Treatment
Global Transrectal Ultrasound Market, by End User
- Diagnostic Laboratories
Global Transrectal Ultrasound Market, by Region
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Spain, Scandinavia, Rest of Europe)
- Asia Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa)
Several Savvy Players to Launch Advanced TRUS Devices; Helping Market to Pick Pace
The competitive landscape of global transrectal ultrasound market is semi-consolidated. The market was dominated by some well recognized brands in 2017. B.K. Holding was one of them, which covered a significant share in the global market for TRUS. Some of the other companies presently functioning in the global TRUS market are TELEMED, Esaote SpA, GE Healthcare, The Prometheus Group, and Exact Imaging.
More Trending Topics from Fortune Business Insights:
Defibrillator Market Size Growth & Industry Dynamics 2026
Diabetes Treatment Devices Market Size, Share & Growth Report 2026
Intravenous Immunoglobulin Market Size, Share | Growth Report, 2025